TrialThe New England journal of medicine2021
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.
Oliver Sartor et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1,454 papers cite itlatest 60 shown
this paperpooled ittrialcites it